Logo Image
News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveClinical Forum InsightsInsightsPeers & PerspectivesPodcastsShortsSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsLive EventsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Behavioral Addictions
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease & Dementia
  • Anxiety Disorders
    • Panic Disorder
  • Cannabis
  • Case Discussions
  • Comorbidity
  • Consultation-Liaison Psychiatry
    • COVID-19
  • Cultural Psychiatry
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Integrative Psychiatry
  • Life Cycle Psychiatry
    • Postpartum Disorders
    • Geriatric Psychiatry
    • Child & Adolescent Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
    • Treatment-Resistant Depression
    • Major Depressive Disorder
    • Bipolar Disorder
  • Neuromodulation
  • Neuropsychiatry
    • Cognition
    • Dementia
    • Autism
  • Obsessive-Compulsive Disorders
  • PTSD, Trauma & Stress Disorders
    • Disaster Psychiatry
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Psychedelics & Cannabis
  • Psychiatry & Society
    • Diversity, Equity, Inclusion
    • Climate Change
    • Media & Psychiatry
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep-Wake Disorders
    • Narcolepsy
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Sports Psychiatry
    • Pervasive Developmental Disorder
    • LGBTQ+
    • Gender Issues
    • Military Mental Health
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
    • Digital Therapeutics
    • Artificial Intelligence
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement

Ramiro Salas, PhD

Advertisement

Dr Salas is an associate professor of Psychiatry Research at Baylor College of Medicine.

Articles by Ramiro Salas, PhD

From Theory to Real-World Practice: Clinical Integration of Digital Therapeutics

ByNidal Moukaddam, MD, PhD,Akane Sano, PhD,Ramiro Salas, PhD,Ashutosh Sabharwal, PhD
August 2nd 2021

Digital therapeutics may be the biggest paradigm-shifting change medicine has seen yet...

Advertisement

Latest Updated Articles

  • From Theory to Real-World Practice: Clinical Integration of Digital Therapeutics
    From Theory to Real-World Practice: Clinical Integration of Digital Therapeutics

    August 2nd 2021



Advertisement
Advertisement

Trending on Psychiatric Times

1

Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia

2

Resuscitating the Biopsychosocial Model in Psychiatry

3

FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease

4

DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial

5

Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us